References
- Arner E, Westermark P, Spalding K, Britton T, Ryden M, Frisen J, Bernard S, Arner P. (2010). Adipocyte Turnover: Relevance to Human Adipose Tissue Morphology. Diabetes 59: 105-109.
- Baker D, Taylor H, Lee S, Barker S, Goad M, Means JC. (2001). Hepatic Toxicity and Recovery of Fischer 344 Rats Following Exposure to 2-Aminoanthracene by Intraperitoneal Injection. Toxicol Pathology 29: 328.
- Boudreau M, Taylor H, Baker D, Means J. (2006). Dietary Exposure to 2-Aminoanthracene Induces Morphological and Immunocytochemical Changes in Pancreatic Tissues of Fisher-344 Rats. Toxicology Sciences 93: 50-61.
- Centers for Disease Control and Prevention (CDC). (2014). National Diabetes Statistics Report: Estimates of Diabetes and Its Burden in the United States, Atlanta, GA: U.S. Department of Health and Human Services.
- Diamanti-Kandarakis E, Bourguignon J-P, Giudice L, Hauser R, Prins G, Soto A, Zoeller T, Gore A. (2009). Endocrine-Disrupting Chemicals: An Endocrine Society Scientifi c Statement. Endocrine Reviews 30: 293-342.
- Ferland-McCollough D, Ozanne S, Siddle K, Willis A,Bushell M. (2010). The Involvement of microRNAs in Type 2 diabetes. Biochemical Society Transactions 38: 1565-1570.
- Fernandez-Real J, del Pulgar S, Luche E, Moreno-Navarrete J, Waget A, Serino M, Sorianello E, Sanchez-Pla A, Pontaque F, Vendrell J, Chacon M, Ricart W, Burcelin R, Zorzano A. (2011). CD14 Modulates Infl ammation-driven Insulin Resistance. Diabetes 60: 2179-2186.
- Gato WE and Means JC. (2011). Pancreatic gene expression altered following dietary exposure to 2-Aminoanthracene:links to diabetogenic activity. Journal of Pharmacology and Toxicology 6: 234-248.
- Gato WE, Hales DB, Means JC. (2012). Hepatic gene expression analysis of 2-aminoanthracene exposed Fisher-344 rats reveal patterns indicative of liver carcinoma and type 2 diabetes. J Toxicol Sci 37: 1001-1016.
- Greenberg AS and Obin MS. (2006). Obesity and the role of adipose tissue in infl ammation and metabolism. Am J Clin Nutr 83(suppl): 461S-5S.
- Guilherme A, Virbasius JV, Puri V, Czech MP. 2008. Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nature Reviews Molecular Cell Biology 9: 367-377.
- Hajer G, van Haeften T, Visseren F. 2008. Adipose tissue dysfunction in obesity, diabetes, and vascular diseases. European Heart Journal 29: 2959-2971.
- Heindel JJ. (2008). Animal models for probing the developmental basis of disease and dysfunction paradigm. Basic & Clinical Pharmacology & Toxicology 102: 76-81.
- Heindel JJ. (2006). Role of exposure to environmental chemicals in the developmental basis of reproductive disease and dysfunction. Semin Reprod Med 24: 168-177.
- Jemnitz K, Veres Z, Torok G, Toth E, Vereczkey L. (2004). Comparative study in the Ames test of benzo[a]pyrene and 2‐aminoanthracene metabolic activation using rat hepatic S9 and hepatocytes following in vivo or in vitro induction. Mutagenesis 19: 245-250.
- Jung UJ and Choi M-S. (2014). Obesity and its metabolic complications: The role of adipokines and the relationship between obesity, infl ammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease. Int J Mol Sci 15: 6184-6223.
- Kwon H, Pessin J. (2013). Adipokines Mediate Infl ammation and Insulin Resistance. Frontiers in Endocrinology 4: 71.
- Linehan E, Dombrowski Y, Snoddy R, Fallon PG, Kissenpfennig A, Fitzgerald DC. (2014). Aging impairs peritoneal but not bone marrow-derived macrophage phagocytosis. Aging Cell 13: 699-708.
- Lönn M, Mehlig K, Bengtsson C, Lissner L. (2010). Adipocyte size predicts incidence of type 2 diabetes in women. FASEB 24: 326-331.
- Makki K, Froguel P, Wolowczuk I. (2013). Adipose Tissue in Obesity-Related Infl ammation and Insulin Resistance: Cells, Cytokines, and Chemokines. ISRN Infl ammation, 12 pages.
- Mattis ND, Jay JW, Barnett GW, Rosaldo JJ, Howerth EW, Means JC and Gato WE. (2014). Profi le of select hepatic insulin signaling pathway genes in response to 2-aminoanthracene dietary ingestion. J Biol Regul Homeost Agents 28(4): 693-704.
- Newbold RR. (2010). Impact of environmental endocrine disrupting chemicals on the development of obesity. Hormones 9: 206-217.
- Olefsky J and Glass CK. (2010). Macrophages, infl ammation, and insulin resistance. Annu Rev Physiol 72: 219-46.
- Patriarca M, Menditto A, Rossi B, Lyon TDB and Fell GS (2000). Environmental exposure to metals of newborns, infants and young children. Michrochemical Journal 67: 351-361.
- Prieto-Hontoria PL, Pérez-Matute P, Marta Fernández-Galilea M, Matilde Bustos M, Martínez JA, Moreno-Aliaga MJ. (2011). Role of obesity-associated dysfunctional adipose tissue in cancer: A molecular nutrition approach. Biochimica et Biophysica Acta (BBA) - Bioenergetics 1807: 664-678.
- Sargis RM, Neel BA, Brock CO, Lin Y, Hickey AT, Carlton DA, Brady MJ. (2012). The novel endocrine disruptor tolylfl uanid impairs insulin signaling in primary rodent and human adipocytes through a reduction in insulin receptor substrate-1 levels. Biochimicaet Biophysica Acta (BBA) - Molecular Basis of Disease 1822: 952-960.
- Tilg H and Moschen A. (2006). Adipocytokines: mediators linking adipose tissue, infl ammation, and immunity. Nature Reviews Immunology 6: 772-783.
- Trouplin V, Boucherit N, Gorvel L, Conti F, Mottola G, Ghigo E (2013). Bone Marrow-derived Macrophage Production. J Vis Exp 81: e50966.
- Vélez-Bermúdez IC and Schmidt W. (2014). The conundrum of discordant protein and mRNA expression. Are plants special? Front Plant Sci 5: 619.
- Walker, M. (2008). Role of MicroRNA in Pancreatic β-Cells. Diabetes 57: 2567-2568.
- Winkler G, Kiss S, Keszthelyi L, Sápi Z, Ory I, Salamon F, Kovács M, Vargha P, Szekeres O, Speer G, Karádi I, Sikter M, Kaszás E, Dworak O, Gerö G, Cseh K. (2003). Expression of tumor necrosis factor (TNF)-alpha protein in the subcutaneous and visceral adipose tissue in correlation with adipocyte cell volume, serum TNF-alpha, soluble serum TNF-receptor-2 concentrations and C-peptide level. Eur J Endocrinol 149: 129-35.